Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dual Targeting with EZH2 Inhibitor and STING Agonist to Treat Melanoma

Journal of Investigative Dermatology(2022)10.1016/j.jid.2021.09.028Source: DataRank Database

Dual Targeting with EZH2 Inhibitor and STING Agonist to Treat Melanoma is a research paper published in Journal of Investigative Dermatology (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.53)OA: greenTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

David E. Fisher ORCID,Abdullah Al Emran ORCID

Live enrichment

PubMed:35131084 PMC:PMC8957612 OpenAlex:https://openalex.org/W4210612530

National Institutes of Health

Grant: 1R01CA222871

National Institutes of Health

Grant: 5P01 CA163222

National Institutes of Health

Grant: 5R01AR043369-22

National Institutes of Health

Grant: R01AR072304

NCI NIH HHS

Grant: P01 CA163222

NCI NIH HHS

Grant: R01 CA222871

NIAMS NIH HHS

Grant: R01 AR043369

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Melanoma Research Alliance

FWCI

0.53

Citation Percentile

0.6%

Citation Trend

2023

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8957612

publisherhttps://api.elsevier.com/content/article/PII:S0022202X21023782?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022202X21023782?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jid.2021.09.028

Fields of Study

interferon and immune responsesImmune cells in cancerCytokine Signaling Pathways and InteractionsEnhancer of Zeste Homolog 2 ProteinHumansImmunotherapyInterferonsMelanomaNeoplasm Recurrence, Local

MeSH Terms

Enhancer of Zeste Homolog 2 ProteinHumansImmunotherapyInterferonsMelanomaNeoplasm Recurrence, Local

Keywords

EZH2Stimulator of interferon genesMelanomaImmunotherapyCancer researchStingImmunologyInterferonMedicineInnate immune systemImmune systemEpigeneticsBiologyGene

Sustainable Development Goals

SDG 0: Good health and well-being